Anixa Biosciences, Inc. (ANIX)
Nasdaq: ANIX · Pharmaceutical Preparations · San Jose, CA · filing with the SEC since 1995
Who runs Anixa Biosciences, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Kumar Amit
Chief Executive Officer. First filing Dec 2012, latest Nov 2, 2026, 40 filings in all.
Officers reporting now
3
of 5 people with a filing in the last fifteen months
Directors reporting now
2
12 people on the record since 2006
Officerssales are open-market, Nov 2, 2025 to Nov 2, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kumar Amit | Chief Executive Officer | Dec 2012 | Nov 2, 2026 | none |
| Titterton Lewis H Jr | Chief Executive Officer | Aug 2010 | Oct 26, 2026 | none |
| Catelani Michael | President, COO, & CFO | Nov 2016 | Sep 30, 2026 | none |
Directorssales are open-market, Nov 2, 2025 to Nov 2, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Baskies Arnold M | director | Sep 2016 | Sep 28, 2026 | none |
| Gottschalk Emily | director | Oct 2019 | Jan 6, 2026 | none |
Earlier names on the record7, newest filing first
Cavalier David · director · last filing Aug 2020Monahan John J · director · last filing Aug 2020Williams Richard H · director · last filing Apr 2018Johnson Bruce F · director · last filing Sep 2017Fox Dale · director · last filing Sep 2017Berman Robert Andrew · officer · last filing Jun 2017Herms Henry P · officer · last filing Oct 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.